Department of Orthopedic Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Department of Orthopedic Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
World Neurosurg. 2023 Oct;178:e712-e719. doi: 10.1016/j.wneu.2023.07.149. Epub 2023 Aug 6.
To assess the cost and effectiveness of percutaneous endoscopic interlaminar discectomy (PEID) and microscope-assisted tubular discectomy (MATD) for patients with L5/S1 lumbar disc herniation (LDH).
The medical and financial records of patients diagnosed with L5/S1 LDH and who underwent either PEID or MATD from April 2021 to April 2022 were retrospectively collected. Demographic and baseline information, perioperative observational index, clinical outcomes, and inpatient costs were analyzed.
Sixty patients were included, with 30 patients in the PEID group and 30 patients in the MATD group. No significant difference was found in demographic and baseline information between the 2 groups (P > 0.05). The PEID group showed significantly shorter incision length, less intraoperative blood loss, shorter hospital stays, and higher intraoperative fluoroscopy frequency compared with the MATD group (P < 0.05). There were no significant differences in visual analog scale back/leg score, Oswestry Disability Index, and 36-Item Short-Form Survey score between PEID and MATD groups before the surgery and at any follow-up time points (P > 0.05). The total cost, surgery cost, and surgical instruments/materials cost were significantly higher in the PEID group compared with the MATD group (P < 0.05). In contrast, the drug and nursing costs were significantly higher in the MATD group than in the PEID group (P < 0.05).
PEID and MATD provide equivalent clinical efficacy and safety in treating LDH at L5/S1 segment within a 1-year follow-up. However, PEID is less invasive and MATD is less costly. No one surgical technique is superior in all aspects and patients should make decisions according to their top concern.
评估经皮内镜下椎间孔入路椎间盘切除术(PEID)和显微镜辅助经皮椎间孔入路椎间盘切除术(MATD)治疗 L5/S1 腰椎间盘突出症(LDH)患者的成本和效果。
回顾性收集 2021 年 4 月至 2022 年 4 月间接受 PEID 或 MATD 治疗的 L5/S1 LDH 患者的医疗和财务记录。分析人口统计学和基线信息、围手术期观察指标、临床结果和住院费用。
共纳入 60 例患者,其中 30 例接受 PEID 治疗,30 例接受 MATD 治疗。两组患者的人口统计学和基线信息无显著差异(P > 0.05)。PEID 组切口长度更短、术中失血量更少、住院时间更短、术中透视频率更高,与 MATD 组相比差异有统计学意义(P < 0.05)。PEID 组和 MATD 组在手术前和任何随访时间点的视觉模拟量表腰背/下肢评分、Oswestry 功能障碍指数和 36 项简短健康调查量表评分均无显著差异(P > 0.05)。PEID 组的总费用、手术费用和手术器械/材料费用明显高于 MATD 组(P < 0.05),而 MATD 组的药物和护理费用明显高于 PEID 组(P < 0.05)。
在 1 年随访期间,PEID 和 MATD 治疗 L5/S1 节段 LDH 的临床疗效和安全性相当。然而,PEID 具有微创优势,MATD 则具有成本优势。没有一种手术技术在所有方面都具有优势,患者应根据自己的首要关注点做出决策。